Caraballo Consulting

Executive Summary

Caraballo Consulting is a specialized boutique consulting firm serving the life sciences industry, with a focus on medical devices, pharmaceuticals, and biotechnology. Founded in 2015 and headquartered in Boston, the company provides tailored expertise in regulatory compliance, clinical affairs, quality assurance, and manufacturing operations. Operating through a collaborative, consultant-led model, Caraballo delivers high-touch, customized solutions to clients navigating complex regulatory landscapes. The firm's deep domain knowledge and personalized approach position it as a trusted partner for both established companies and emerging innovators seeking to accelerate product development and market access. As a private company with no disclosed funding or valuation, Caraballo Consulting operates with agility and discretion. Its revenue stability is supported by recurring demand for regulatory and quality consulting services, driven by evolving FDA guidelines, post-market surveillance requirements, and the increasing complexity of global compliance. While the firm faces competition from larger consultancies, its boutique structure enables closer client relationships and faster response times. With the life sciences sector continuing to expand and regulatory scrutiny intensifying, Caraballo is well-positioned to maintain steady growth and deepen its niche expertise.

Upcoming Catalysts (preview)

• Q3 2026FDA Final Guidance on Artificial Intelligence/Machine Learning in Medical Devices85% success
• Q4 2026Expansion of Consulting Services into Gene Therapy and Cell Manufacturing60% success
• Q2 2026Strategic Partnership with a Mid-Size Biotech for Regulatory Outsourcing50% success